Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines. by Abbs, I, Clark, M, Waldmann, H, Chatenoud, L, Koffman, C, Sacks, S